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Abstract:  
Psoriasis is a proliferative inflammatory skin disorder with relapsing episodes. Herein, the 
efficacy of babchi oil (BO) loaded nanostructure gel was evaluated for antipsoriatic activity 
and oxidative stress biomarkers assessment using mouse tail model. BO was entrapped into 
cyclodextrin-based nanocarriers (360.9±19.55 nm), followed by incorporation into a 
Carbopol gel and characterized for viscosity, spreadability and texture analysis. The gels 
were topically applied on mouse-tails once daily for fourteen days. Evaluation of antipsoriatic 
activity as determined by histopahological observations of orthokeratotic epidermis revealed 
two times higher efficacy of BO nanogel than the native BO gel. Further, significantly 
enhanced superoxide dismutase (SOD) and reduced glutathione (GSH) levels and diminished 
malondialdehyde (MDA) and nitrite (NO) levels revealed that nanogels played a major role 
in management of ROS associated in psoriasis pathogenesis. Hence, this study provides 
strong evidence for use cyclodextrin-based nanogels as safe and better delivery carrier of BO 
for management of psoriasis. 
Keywords: Cyclodextin-based nanostructures; babchi oil; carbopol gel; mouse-tail model; 
lipid peroxidation; antioxidant enzymes.  
 
 
1. Introduction 
Psoriasis is one of the recurrent and chronic inflammatory disorder native to painful, scaly, 
itchy skin resulting in disfiguring lesions. More than 125 million people are estimated to be 
suffering from this disease worldwide [Langan et al., 2012, World Health Organization. 
Global report on psoriasis, 2016]. The impact of skin diseases such as psoriasis is generally 
underestimated since “a person hardly ever dies from a skin disease” but these can be very 
troublesome and has significant psychosocial embarrassment and cause deterioration in 
patient’s quality of life.  
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Psoriasis manifests itself by hyperproliferation and altered differentiation of keratinocytes 
[Suresh et al., 2013]. It is associated with various immunological and biochemical 
disturbances and involves multitude of coherent events including activation of circulating 
immune cells along with their secreted signalling molecules like chemokines, cytokines and 
growth factors resulting in congealing of epidermis, hyperkeratosis and neovascularisation 
[Pradhan et al., 2013].  
Since the pathogenesis of psoriasis includes a complex series of molecular phenomena, 
various treatment strategies involving topical, systemic and phototherapy have been 
employed for its management [Paul et al., 2011]. Scientific information supports that topical 
therapy is still the mainstay for approximately 70% of patients, while remaining 30% 
condition is largely managed with systemic pharmacotherapy [Carrascosa et al., 2006]. Also, 
topical mode very often remains compliment part of the systemic treatment regimen. Topical 
medications for psoriasis include corticosteroids, topical retinoids, athralin, calcineurin 
inhibitors etc. However, these synthetic drugs have their own limitations [Carrascosa et al., 
2006, Menter et al., 2007, Paul et al., 2011]. Therefore, there is imperative need of alternative 
safer and effective treatments for psoriasis. 
There has been renewed interest in natural products based research due to failure of 
alternative drug discovery techniques in delivering therapeutic moieties [Lahlou, 2013]. 
Essential oils are complex compounds present in aromatic plants as secondary metabolites 
and possess two or more bioactives in relatively higher concentrations (20-70%) [Bakkali et 
al., 2008]. One such essential oil, babchi oil provides alternative treatment for psoriasis with 
least side effects as compared to the synthetic drugs recommended for this disease [Marwaha 
and Bhise, 2014, Kumar and Rao, 2016, Raut and Wairkar, 2018]. In Ayurveda and 
traditional Chinese medicine, babchi oil has been suggested for treatment of skin diseases due 
to its anti-microbial, antioxidant and anti-inflammatory properties [Chopra et al., 2013]. 
Obtained from Psoralea corylifolia seeds (family leguminoseae), this essential oil is a 
phytotherapeutic agent with furocoumarins as major constituents that restrain DNA synthesis 
and cause retardation of cell proliferation, resulting in anti-psoriatic action [Khushboo et al., 
2010]. Although, there are several ayurvedic formulations of babchi oil in Indian market, 
however, psoralen has not been assessed from traditional commercial preparations. In 
addition, pharmacokinetics of any traditional preparation has not been reported in literature 
using psoralen [Shailajan et al., 2012]. Besides this, BO suffers from instabilities resulting 
from oxygen, temperature and light that can lead to its oxidation and degradation. Further, 
skin irritation and toxicity of babchi oil are other issues needed to be handled. These 
shortcomings limit its practical use of BO inspite of its promising antipsoriatic potential. In 
previous reports, limited BO-based formulations have been reported, encompassing 
nanostructure lipid carriers and microsponges [Faiyazuddin et al., 2010, Wadhwa et al., 
2019].  
The use of colloidal drug carriers is of great interest for skin delivery of therapeutic agents 
[Pople and Singh, 2011]. Not only they improve penetration of drugs into the skin but also 
allow their extended drug release and reduce skin-irritating effect of the topical agents [Pople 
and Singh, 2013, Robert et al., 2017]. There is an increased interest in scientific community 
for delivering phytocompounds as nanocarriers, which has emerged as a potential alternative 
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strategy for management of skin disorders [Sampada and Singh, 2015, Falcão et al., 2018]. 
There is no marketed novel formulation of the babchi oil that overcomes the above mentioned 
problems of the BO. Encapsulation of essential oils in nanocarriers including nanostructured 
lipid carriers [Nahr et al., 2018], liposomes [Low et al., 2013, polymeric nanoparticles [Dima 
et al., 2014], niosomes [Leelarungrayub et al., 2017], solid lipid nanoparticles [Moghimipour 
et al., 2013] has been employed to improve their stability as well as efficacy [El Asbahani et 
al., 2015]. Cyclodextrin based nanostructures are novel multifunctional nanoskilled systems 
composed of biocompatible cross-linked polymers. These are highly porous nanostructures 
with 3-dimensional rings and nanometric cavities with unique capacity to entrap active 
molecules offering the benefit of programmable release [Trotta et al., 2012]. These can be 
explored as a novel approach to stabilize essential oils and increase their efficacy [Aldawsari 
et al., 2015, Bachir et al., 2017]. Nanostructures have also shown remarkably improved drug 
permeation of a phytoconstituent in in vitro assays carried out using porcine skin [Ansari et 
al., 2011, Sapino et al., 2013]. Additionally, cyclodextrins have been well established in 
literature to alleviate local irritancy and promote drug transport, which is particularly 
important attribute in treating psoriasis [Wadhwa et al., 2017] as the skin in this disorder 
(being rough and ingrained with plaques) impose as major barrier in topical delivery of drugs 
[Pradhan et al., 2013].  In our previous work, we developed babchi oil loaded nanosponges 
which were partially characterized in regard of cytotoxicity, photostability and antimicrobial 
studies [Kumar et al., 2018]. However, it is essential for the formulation scientists to study 
the pharmacological efficacy of prepared formulation. In addition, for dermal nanomedicines, 
the targeting potential is also an important parameter to manage the psoriasis. Hence, in the 
present work, cyclodextrin based nanostructures of babchi oil and its gel was fabricated and 
characterized comprehensively using photon correlation spectroscopy, transmission electron 
microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), differential scanning 
calorimetry (DSC), viscosity studies, texture analysis and in vitro release studies. In vivo anti-
psoriatic efficacy of the babchi oil nanostructure gels was determined using mouse tail model. 
As per literature reports, it has been suggested that insufficient antioxidant defence system 
due to increased ROS (reactive oxygen species) generation and NO (nitric oxide) may be 
responsible for contribution of pathogenesis of psoriasis [Shen et al., 2008, Kadam et al., 
2010, Oršolić et al., 2014]. Therefore, detailed biochemical estimation in terms of lipid 
peroxidation (LPO) by measurement of malondialdehyde (MDA) levels, nitric oxide (NO) 
production and estimation of vital enzymes involved in the antioxidation process including 
glutathione and superoxide dismutase (SOD) activity have been carried out to assess the 
oxidative stress and effect of treatment with babchi oil nanogels on these parameters have 
been determined. To the best of our knowledge, it is the first report on babchi oil being 
incorporated in cyclodextrin based nanogel and its detailed biochemical investigation in 
mouse tail psoriasis model. 
 
2. Materials and methods 
2.1. Materials 
Babchi oil (BO) and β-cyclodextrins were supplied ex-gratis by Pukhraj Herbals, Mandsaur 
(India) and Jay-Chem Marketing, Mumbai (India), respectively.  The crosslinker diphenyl 
carbonate (DPC), carbopol 934 and triethanolamine was procured from Sigma Aldrich, Milan 
(Italy), LOBA chemie Pvt. Ltd. Mumbai (India) and S D Fine-Chem Ltd., Mumbai (India), 
respectively. All other reagents and chemicals used were of analytical grade. Double distilled 
water was used throughout research.  
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2.2. Engineering of babchi oil nanostructures (BONS)  
Cyclodextrin-based nanostructures were engineered using previously reported method 
[Kumar et al., 2018, Rao et al., 2013, Rao et al., 2017]. Briefly, anhydrous β-CD and 
diphenyl carbonate in molar ratio of 1:4 [Kumar et al., 2018] were heated to 95 °C on 
magnetic stirrer for 6 hrs. The mixture was cooled to ambient temperature and washed with 
water to remove β-CD (unreacted), followed by soxhlet extraction using acetone, to remove 
DPC (unreacted) and phenol. The obtained nanostructures were put at 40 °C in hot air oven 
for 2 hrs. 
Babchi oil-loaded nanostructures (BONS) were prepared by freeze-drying technique 
[Swaminathan et al., 2013]. The fabricated nanostructures and babchi oil in ratio 1:4 were 
suspended in Milli-Q water (50 ml) and was kept on magnetic stirrer for 24 hrs. The 
dispersion was centrifuged at 1500 rpm for 10 min to separate unentrapped essential oil from 
the colloidal supernatant. The nanostructures were freeze dried in a Lyophilizer (Alpha 2-4 
LD Plus CHRIST, Osterode, Germany). Typical freeze drying cycle consisted of 24 hrs at 
temperature (-81 C) and operating pressure (0.0010 mbar). The lyophilized powder was 
stored in desiccators [Anandam and Selvamuthukumar, 2014]. 
2.3. Characterization and evaluation of BO nanostructures 
2.3.1. Particle size, surface charge and morphology 
The sizes and polydispersity indices of BO nanostructures were examined using Malvern 
Zetasizer (Malvern Instruments Ltd, UK) using photo correlation spectroscopy. Zeta potential 
examinations were carried out using an additional electrode in the same instrument.  
Transmission electron microscopy was employed to evaluate the topography of BONS. The 
samples were suspended in double distilled water. The sample was placed on carbon-coated 
copper grid and subsequently viewed under microscope at various magnifications using TEM 
(FEI Tecnai G
2
 20 S-Twin, USA). 
2.3.2. Entrapment efficiency 
A weighed quantity (5 mg) of BONS was suspended in DMSO followed by sonication for 10 
min to release the essential oil form the nanostructure complex. The absorbance of the 
samples was recorded by UV spectrophotometer (Varian Cary -5000, Netherland) at 265 nm 
to calculate babchi oil content in nanostructures. The entrapment efficiency was calculated 
using the formula [Shende et al., 2012]: 
𝐸𝑛𝑡𝑟𝑎𝑝𝑚𝑒𝑛𝑡 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦(%) =
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑏𝑎𝑏𝑐ℎ𝑖 𝑜𝑖𝑙 𝑖𝑛 𝑛𝑎𝑛𝑜𝑠𝑡𝑟𝑢𝑐𝑡𝑢𝑟𝑒𝑠
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑏𝑎𝑏𝑐ℎ𝑖 𝑜𝑖𝑙 𝑓𝑒𝑑 𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑙𝑦
× 100  
 1 
 
2.3.3. Differential scanning calorimetry  
Differential scanning calorimetry of BO (Babchi oil), BONS (Babchi oil loaded 
nanostructures), BNS (Blank nanostructures), DPC (Diphenyl carbonate) and β-CD (β-
Cyclodextrin) was carried out using TA instruments, California (Discovery DSC25 series) 
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equipped with a Refrigerated Cooling System 90 (RCS 90) and TRIOS software. The DSC 
instrument was graduated with indium for heat of enthalpy and melting point. A heating rate 
(10 ºC/min) was applied in the 30-350 ºC temperature range under nitrogen purge (50 
ml/min). Standard aluminium empty pan (Perkin-Elmer) was used as reference standard.  
 
2.4. Incorporation of BO and BONS in Carbopol gel 
Carbopol 934 was used as the suitable gelling agent on the basis of its feel, ease of 
spreadability and compatibility with nanostructure dispersions. To this effect, BONS 
(equivalent to 5%w/v BO) was uniformily mixed in Carbopol 934 solution (1% w/v) and pH 
was maintained with triethanolamine resulting in nanogels [Mandawgade and Patravale, 
2008]. In the similar way, plain Carbopol and BO loaded gel (5%w/v) was also prepared for 
comparison. 
2.5. Evaluation of BONS loaded gels 
2.5.1. Fourier Transform Infrared spectroscopy 
Pure babchi oil (BO), blank gel, BO gel (5% w/v) as well as BONS gel (5% w/v) were 
subjected to FTIR spectroscopic analysis by using a Perkin-Elmer system, Spectrum BX 
spectrophotometer, Waltham, USA. FTIR spectra were examined over the range 4,000 to 400 
cm
-1
 with 16 scans and a resolution of 2.00 cm
-1 
[Johny et al., 2011, Gaikwad et al., 2012].  
2.5.2. Viscosity studies 
The viscosity studies on the gels (plain gel, BO gel and BONS gel) were performed using 
slightly modified method as reported previously [Sharma and Pathak, 2011] on a 
programmable Brookfield viscometer (model DV-E) at 25 ºC. Spindle (No - 6) was lowered 
down perpendicularly into the fabricated gel placed in container taking care that the spindle 
does not touch the bottom of the container. The spindle was rotated at increasing speed from 
0.5 to 100 rpm and the viscometer readings were noted after 60 sec when the level of gel gets 
stabilized. Results were plotted between viscosities versus shear rate. 
2.5.3. Spreadability  
 
 
The spreadability of fabricated gels was examined using parallel plate method reported in 
previous studies [Marchiori et al., 2010, Doppalapudi et al., 2017]. Briefly, plain, BO and 
BONS gels (0.5 g each) were placed at the centre of glass slide and above it, another slide 
was positioned concentrically. Initial diameter of gel formulations was measured as diameter 
of circle, in which the gels were spread. Known weights (15, 20, 30, 50, 70, 100, 150 and 200 
g) were positioned gradually on the upper plate at fixed time interval (1 min). Subsequently, 
spreadability of gels was assessed on the basis of change in area on application of weights. 
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Increase in spreading diameter was measured in horizontal and vertical axes after every 
addition of weight. Results were demonstrated in terms of the spreading area as per following 
equation: 
𝑆 = 𝜋𝑑2 4⁄            2 
where S represents spreading area (cm
2
) and  d represents the mean diameter (cm) for each 
sample. Spreadability patterns were established by plotting the applied weights on x-axis 
against spreading area on y-axis. These experiments were carried out in triplicate.  
2.5.4. Texture analysis 
The texture analysis was carried out using TA-XT2i Texture analyser with specific 
instrument setting. Penetration tests were performed using a cylindrical probe having 
diameter 25.0 mm (P25/L5). The experiments were performed on plain gel, BO gel (5%w/v) 
and BONS gel (5%w/v). Furthermore, for an appropriate comparison, a plain carbopol (1 % 
w/v) gel was also evaluated. The gel sample formulations were formulated in cylindrical 
shape beakers; sample heights lies in the range 40.0 ± 0.1 mm (having diameter 45.0 ± 0.1 
mm). At ambient temperature, the carbopol gel resistance for penetration and withdrawal of 
the cylindrical probe was measured. The pre-test speed, the test speed and the post-test speed 
were fixed at 1.0 mm/s, 0.5 mm/s, and 10.0 mm/s, respectively, and 0.05 N trigger force was 
applied. Three replicates were performed for each gel sample. From penetration/withdrawal 
investigation, various parameters like work of cohesion representing the work required to 
conquer the internal bonds of the gel  (the positive area upto maximum value under the force-
time curve), hardness representing the maximum positive force needed to achieve a given 
deformation (Fmax), the work of adhesion  depicting the work required to pull the probe off 
from the gel (the negative area under the force-time curve) and springiness representing the 
rate at which a deformed sample reforms (elasticity), were derived [Coviello et al., 2015]. 
2.6. In vitro release studies 
To counteract solubility challenges of babchi oil, a modified assay was adopted to check the 
actual release of babchi oil from the nanogel formulation. In brief, 1 gm of BONS gel 
(equivalent to 5% w/v of babchi oil) was added in a dialysis bag (molecular weight: 12000 to 
14000 Da, pore size: 2.4 nm, Himedia). This dialysis bag was suspended in a 250 mL of PBS 
having pH 5.5, at 37°C and rotated at 50 rpm. At pre-determined intervals, 5 ml of PBS was 
collected and subsequently replaced with same amount of fresh dissolution media at same 
temperature. The collected samples were analysed using ultra-violet visible 
spectrophotometry. Further, the length of the dialysis bag was also kept same for all 
experiments in order to keep the surface area constant [Hua, 2014, Elmeshad et al., 2014].  
2.7. In vivo anti-psoriatic activity studies 
2.7.1. Animal and maintenance 
Healthy female Swiss albino mice, weighing 20-25 g, aged four to six weeks were obtained 
from the Experimental Animal Facility, Guru Jambheshwar University of Science and 
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Technology, Hisar, India. The mice were acclimatized for seven days prior to the treatments. 
The animals were housed in polypropylene cages under standard laboratory environment with 
12 hrs light and dark cycle at ambient temperature (24-26 
o
C) and relative humidity (50-
52%). The animals had free access to food and water. Taking consideration that the research 
study strictly follows the guidelines for use and care of the laboratory animals, all the present 
experiments were carried out as per the protocol approved by the Guru Jambheshwar 
University of Science and Technology Animal Ethics Committee (Ref. letter no. 
IAEC/2016/26-34 dated on 05/12/2016). 
 
2.7.2. Experimental design and treatment 
Following seven days of acclimatization, the animals were randomized into six experimental 
groups (six animals each): (1) naive group, untreated animals; (2) sham-animals treated with 
blank Carbopol 1%w/v gel; (3) animals treated with BO loaded gel (5%w/v); (4) animals 
treated with BO loaded gel (10%w/v); (5) animals treated with BONS (equivalent to 5%w/v 
BO) loaded gel; (6) animal treated with CP loaded gel (0.05%w/v). The Plain BO was not 
chosen for evaluation owing to stability and ethical concerns [Kumar et al., 2018]. 
2.7.3. Mouse tail model 
The anti-psoriatic potential of the prepared nanogels was investigated using a mouse tail 
method as per the protocol given in Fig. 1 [Bhatia et al., 2014]. The gel formulations (100 mg 
each) were applied using brush (once daily) to proximal part of tail for fourteen days. After 
application, the area was covered with sterile plastic film with the help of adhesive tape. The 
mice were humanely sacrificed 24 hrs after the last application of gel formulations by giving 
anaesthesia (overdose of pentobarbitone sodium), and their tails were removed. Following 
this, the tail of animals were used for hematoxylin and eosin staining (for histopathological 
evaluation) and for the biochemical assays. The tail samples were stored in deep freezer (-80 
ºC) till further processed. 
 For histological studies, the tail skin was dissected longitudinally with a blade and 
underlying cartilage was removed [Bhatia et al., 2009]. The resulting skin samples were 
stained with haematoxylin-eosin. The obtained samples were examined for epidermal 
thickness and also for the significant granular layer occurrence in scaly regions. 
Orthokeratosis induction was quantified by assessing granular layer (A) length and scale (B) 
length. Ten subsequent scales were measured for each skin section. Percent orthokeratosis 
was determined using Equation (3). 
% 𝑂𝑟𝑡ℎ𝑜𝑘𝑒𝑟𝑎𝑡𝑜𝑠𝑖𝑠 = (𝐴 𝐵⁄ ) × 100         3 
 Drug activity (DA) represents the enhancement in percentage of orthokeratotic area per scale 
30, which was calculated using Equation (4): 
𝐷𝐴 =
𝑀𝑒𝑎𝑛 𝑂𝐾 𝑜𝑓 𝑇𝑟𝑒𝑎𝑡𝑒𝑑 𝑔𝑟𝑜𝑢𝑝−𝑚𝑒𝑎𝑛 𝑂𝐾 𝑜𝑓 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑔𝑟𝑜𝑢𝑝
100−𝑚𝑒𝑎𝑛 𝑂𝐾 𝑜𝑓 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑔𝑟𝑜𝑢𝑝
× 100     4 
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where OK is percent orthokeratosis [Bhatia et al., 2014]. 
2.8. Biochemical assessments 
The tail samples stored in deep freezer (-80 ºC) were taken out and processed for biochemical 
estimations. Tail skin were weighed and diluted in 1/10 proportion with phosphate buffer 
saline (100 mmol/L, pH 7.4). The tissues were mechanically homogenized for 1 min. The 
homogenate was centrifuged at 7000 rpm for 15 min. The resulting supernatant was subjected 
to biochemical estimation. 
 
2.8.1. Nitrite estimation 
Since, nitrite accumulation is an indicator of nitric oxide (NO) production, its accumulation 
was estimated using Greiss reagent as described in previous studies [Green et al., 1982]. To 
measure, nitrite levels, equal volumes (0.5 ml) of supernatant and Greiss reagent were mixed 
at room temperature and incubated for 10 min in dark. Absorbance was examined at 540 nm 
through UV-Visible spectrophotometry. The nitrite concentration in the sample was 
calculated from sodium nitrite standard plot. 
2.8.2. Superoxide dismutase potential  
Superoxide dismutase potential was checked by method described earlier [Kono, 1978]. 
Briefly, the method is based on inhibition of nitro blue tetrazolium reduction by SOD, which 
was examined at 560 nm by spectrophotometry. Here, the reaction was initiated on addition 
of hydroxylamine hydrochloride to the nitro blue tetrazolium and sample mixture.  Activity 
was revealed as units/mg protein, wherein one unit of SOD is defined as the quantity of 
enzyme causing 100 percent rate of reaction inhibition. 
2.8.3. Measurement of reduced glutathione 
Reduced glutathione estimation was determined as per method described [Ellman, 1959]. 
Briefly, 1.0 ml of homogenate was mixed with 1.0 ml of sulfosalicylic acid (4%w/v) and the 
reaction mixture was kept for 1 h at 4 °C for precipitation, instantly followed by 
centrifugation at 1,200 × g at 4 °C for 15 min. The reaction mixture comprised 0.1 ml of 
supernatant, 2.7 ml of 0.1 mmol/L of phosphate buffer (pH 8.0), and 0.2 ml of Ellman’s 
reagent resulting in yellowish colour and absorbance was recorded instantly at 412 nm 
through UV-visible spectrophotometry. Results were expressed using the absorbance 
coefficient of chromophore (1.36 × 104 M
−1
/cm) of GSH per mg protein. 
2.8.4. Lipid peroxidation measurement 
The quantitative estimation of lipid peroxidation was done as per previous method [Will, 
1966]. The malondialdehyde content was determined by the reaction with thiobarbituric acid 
(TBA) at 532 nm through UV-visible spectrophotometry. The values were determined using 
the absorption coefficient of chromophore (1.56 × 105 M
−1
/cm) of MDA-TBA complex. 
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2.8.5. Protein estimation 
Estimation of protein was carried out by biuret method taking bovine serum albumin as 
standard measuring absorbance at 540 nm through UV-Visible spectrophotometry [Gornall et 
al., 1949].  
2.9. Statistical analysis 
Graph Pad Prism (GraphPad Software Inc, San Diego, CA, USA) was subjected to all 
statistical investigations. The results were described as mean ± SEM. The biochemical 
estimations were evaluated by one-way ANOVA followed by Tukey’s post test. In all tests, 
p<0.05 was considered as criteria for statistical significance. 
3. Results and discussion 
Recent innovation in nanotechnology-based anti-psoriatic drug delivery shows a positive 
prospective in the psoriasis management therapy [Pradhan et al., 2013; Rahman et al., 2015]. 
However, regardless of so much work done on formulation development and preclinical 
reports, only very few clinical studies have been carried out to establish the clinical benefit of 
such novel nanoformulations. Although, topical treatment is the first line approach prescribed 
for patients with mild to moderate psoriasis [Katare et al., 2010]. But, most of the topical 
nanoformulations reported previously, were mainly composed of synthetic chemical lipids 
and surfactants which may be problematic in skin sensitive patients [Ali et al., 2008]. 
Therefore, surfactant free composition of nanostructures may prove as an added advantage of 
this disorder. Nanostructures have superior perspective like, to control structure of 
nanoparticles and, nature and size of pores by varying cross-linker: polymer molar ratio and 
degree of cross linking, which affect drug loading and its release [Trotta et al., 2012, Sherje et 
al., 2017, Prasad et al., 2018]. Further, babchi oil may play a significant role as an alternative 
if delivered efficiently in psoriasis management. In present investigation, BONS were 
successfully fabricated using β-cyclodextrin and diphenyl carbonate and loaded in Carbopol 
gel [Tejashri et al., 2013].  
3.1. Particle size, surface charge and morphology of developed nanostructures 
The particle size of BONS was observed as 360.9±19.55 nm.  Zeta potential (measure of 
surface charge) of BONS was found as -16.0±4.15 mV which may be due to higher repulsive 
forces and minimized tendency to aggregate. Low values of PDI (0.311±0.059) with narrow 
range advocated the homogenous and stable nature of nanocolloidal formulation. 
Using TEM, a single crystal of nanostructure can be focused and its definite crystalline 
geometry can be elucidated. As shown in TEM photographs (data not shown), the size of 
nanoformulation agreed well with zeta sizer findings.  The topography using this microscopy 
showed that the nanostructures fabricated by melt method have uniform size distribution with 
crystalline and porous nature.  
3.2. Entrapment efficiency 
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Entrapment efficiency of prepared BONS was found in the range between 93.05±0.28 %. 
Despite the lipophilic nature of the babchi oil, the developed nanostructures were able to 
offer a very high entrapment value [Aldawsari et al., 2015]. This could be due to firstly, 
crystalline nature of nanostructures formed by melt method; secondly, crosslinked network 
generating nanochannels along with β-CD nanocavities. The size of crosslinked network 
forming nanochannles depends on structural features of crosslinker and cyclodextrins 
[Tejashri et al., 2013, Olteanu, et al., 2014]. 
3.3. Differential scanning calorimetry 
In DSC thermograms, when guest moieties get entrapped into pores of the nanostructures, 
their boiling, melting or sublimating points generally shifted to different temperature or 
disappear [Shende et al., 2015]. The endothermic peak at 80 ºC (enthalpy: 109.3 J/g) of DPC 
indicated its melting point and further, one more endothermic peak at 179 ºC (enthalpy: 39.42 
J/g) indicated its degradation (Fig.2a). In case of β-CD, the first peak observed at 126 ºC  
(enthalpy: 328.26 J/g) was associated with release of water from β-CD [Abarca et al., 2016] 
and second peak at 301 ºC (enthalpy: 179.94 J/g) was associated with melting point of β-CD 
(Fig.2a) [Sarfraz et al., 2017]. The endotherm in case of blank nanostructures showed a shift 
of 10 ºC (116 ºC; enthalpy: 453.86 J/g) and 5 ºC (296 ºC; enthalpy: 73.65 J/g) when 
compared to β-CD (Fig.2a). Babchi oil (BO) showed an endothermic peak at approx. 238 ºC 
(enthalpy: 16.65 J/g), which was found absent following its inclusion into nanostructures 
(BONS), confirming encapsulation of oil within the cyclodextrin nanostructures and offering 
protection to this essential oil (Fig. 2a) [Swaminathan et al., 2010]. BONS thermogram 
exhibits an endothermic peak at 302 ºC (enthalpy: 4.88 J/g), which distinctly differs from the 
peak of blank nanostructures (BNS) (Fig. 2a). The lower phase transition temperature 
confirmed the occurrence of inclusion phenomenon between the nanostructure and BO (Fig. 
2a). This is in corroboration with previous reports [Ansari et al., 2011, Dora et al., 2016].  
3.4. Incorporation of babchi oil and babchi oil loaded nanostructures in carbopol gel 
Carbopol 934, is a high molecular weight synthetic polymer containing carboxyl groups. In 
water, it swells upto1000 times its original volume to form a gel having pH 4.0 to 6.0 [Guo et 
al., 2003]. Further, it is reported as non-irritant and non-sensitizing on long term use and is 
classified as Category 1 GRAS (Generally Recognized As Safe) agent and reported safe by 
Cosmetic Ingredient Review Expert Panel [Elder, 1982]. In gel form, it is an excellent 
medium for drug delivery. Owing to high molecular weight, it cannot permeate the skin, 
hence result in potential dermal action via depot formation of BONS, especially in case of 
psoriasis.  
3.5. Evaluation of BO and BO nanogel 
3.5.1. Fourier Transform Infrared Spectroscopy 
Infrared spectra of blank gel, BO gel (5%w/v) and BONS gel (5%w/v) were used to study the 
compatibility between BO and polymeric gel. The FTIR spectrum of the babchi oil (BO) 
showed characteristic peaks at 3419, 2929, 1740, 1612, 1514, 1456, 1377, 1169 and 724 cm
-1 
(Fig.2b). 
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The intensity of observed bands for babchi essential oil was found to be reduced in BO gel 
(prominent peaks: 2079, 1637, 1451, 1241, 1169,1093 and 676 cm
-1
; Fig.2b) and found 
further reduced in BONS gel (prominent peaks: 2066,1636, 1269, 1155, 1026 and 681 cm
-1
; 
Fig.2b), indicating encapsulation of BO in nanostructures [Swaminathan et al., 2010]. 
Further, FTIR of plain Carbopol gel showed IR bands at 3448 cm
-1
, 2073 cm
-1
, 1637 cm
-1
 and 
675 cm
-1
 (Fig.2b). These bands were also present in BO gel as well as BONS gel, indicating 
absence of any interaction between essential oil and Carbopol gel and BONS and Carbopol 
gel (Fig. 2b) [Garala et al., 2013].  
3.5.2. Viscosity  
Rheological behavior of topical formulations has a significant impact on the spreadability of 
the formulation, contact time and its retention on the skin [Mortazavi and Tabandeh, 2005, 
Lee et al., 2009]. Therefore, viscosity profiles of the BO gel (5%w/v), plain Carbopol gel and 
BONS gel (5%w/v) were studied. A plot of the shear rate versus the measured viscosity of all 
the prepared gels showed decrease in viscosity with increasing shear rates (Fig. 3a) indicating 
pseudoplastic (Shear thinning) behaviour of the gel formulations. Such behaviour is a 
desirable feature for topical preparations, as they should remain thin during application and 
thick otherwise [Labib and Farid, 2015]. Further, it was observed that the viscosity of the BO 
gel was higher which could be due to highly viscous nature of the native babchi oil. As 
anticipated on encapsulation of BO into nanostructures the viscosity of the gel dropped and 
was equivalent to the plain Carbopol gel because of unavailability of the free oil in the gel 
[Batheja et al., 2011]. 
3.5.3. Spreadability 
BO nanogels were fabricated by addition of BO nanostructures to Carbopol gel base which 
enhances BONS retention on the skin surface. Potency of a dermal delivery system depends 
on spreading behaviour of gel in an evenly manner to administer therapeutic dose. Further, 
this important property is important for appropriate dosage deportation to skin along with 
ease of application [Garg et al., 2002]. Hence, the spreadability of prepared gels was checked 
to verify the ease of application of the formulations. Fig. 3b depicts the spreadability 
behaviour of plain gel, BO gel (5%w/v) and BONS gel (5%w/v). Initial spreading area for 
plain gel and BO nanogel was 18.85 ± 1.2 and 17.64 ± 0.15 cm
2
, respectively, whereas BO 
gel exhibited minimum spreading area (16.13 ± 0.89 cm
2
)
 
owing to high viscosity of the 
babchi oil. With 200 g weights, the spreading area was 122.88 ±0.65, 129.47 ± 0.81 and 
121.91 ± 0.99 cm
2
 for plain gel, BONS gel and BO gel, respectively. No significant change in 
spreadability was detected between plain gel and BONS gel. However, spreadability profile 
of BO gel was observed less in comparison to plain gel and nanogel as indicated form 
spreading area-weight curve (Fig 3b). Thus results are in line with viscosity measurements. 
Higher viscosity of BO gels could probably be responsible for its lower spreadability. 
However, inclusion of BO in cyclodextrin nanostructures resulted increase in its spreading 
area as compared to BO gel indicating that encapsulation of oil improved the capacity of the 
gel to spread over wider area and thus making it better suitable for topical delivery.  
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3.5.4. Texture analysis 
To carry out mechanical characterisation of plain gel, BO gel and BONS gel, texture analyser 
was used. The peak height of force-time plot provides hardness of gel formulations. It defines 
the resistance to compression demonstrating the ease of gel removal from container [Bansal 
et al., 2009]. 
The BO gel showed maximum hardness (0.51±0.01 N) followed by BONS gel (0.25±0.01 N) 
while blank gel (0.24±0.07 N) showed less hardness. The adhesiveness was found to be 
consistent with hardness of gels i.e. BONS gel (-1.13±0.18 N sec) being more adhesive than 
BO gel (-4.36±0.22 N sec) followed by Plain gel (-4.48±0.22 N sec). Cohesiveness illustrates 
the structural recovery of gel following compression. The work of cohesion of gel was found 
in order: BONS gel (0.84±0.035) > BO gel (0.81±0.005) > plain gel (0.76±0.034). The 
springiness of gel was found in order: BO gel (0.90±0.036) ˂ BONS gel (0.91±0.056)˂ plain 
gel (0.93±0.109).  
As gel formulations fabricated for topical delivery should possess low hardness and high 
cohesiveness; our results for texture analysis of prepared BO nanogel were found suitable for 
topical application. Further, the higher adhesiveness is another feature desired for prolonged 
retention of formulation in skin, which is characteristic in BO nanogel (Table 1). Hence, 
BONS gel was found to possess all the attributes desired for dermal delivery.  
 
3.6. In vitro release analysis 
 
The in vitro release pattern of babchi oil from nanogel was compared with BO gel. The 
results indicated that approximately 99.91 ± 0.52% babchi oil was released from the 
conventional BO gel within 4 hrs. In vitro release data of BONS gel showed that babchi oil 
release was slower in comparison to plain BO gel. Nanogels were found to exhibit sustained 
release of BO (Fig. 4a). Babchi oil released form BONS gel was approximately 34.21±0.62% 
in 24 hrs signifying the role of nanostructures to cater sustained release of encapsulated 
essential oil over prolonged time [Aldawsari et al., 2015]. Incorporation of nanoformulation 
in hydrogel may serve as a local depot for sustained drug release and provide a rate limiting 
matrix barrier for modulating its drug release as observed in present investigation [Trotta et 
al., 2012]. These results were supported by FTIR studies of BONS gel. Similar results were 
obtained with econazole nitrate nanosponge fabricated using ethyl cellulose as polymer and 
subsequently loaded in hydrogel [Sharma et al., 2011]. BO release over long time period 
would help in averting periodic administration of oil improving the safety and patient 
compliance of long term therapy in psoriasis [Pradhan et al., 2013].  
 
3.7. In vivo anti-psoriatic activity 
Disrupted epidermal proliferation and keratinisation are the major aspects of psoriatic skin. 
Parakeratotic condition (hallmarks of psoriasis) is recognized in the adult mouse tail. The 
mouse tail is widely used animal model to examine the antipsoriatic potential of topical active 
moieties and their formulations with regards to the induction of orthokeratosis [Hofbauer et 
al., 1988, Sebok et al., 2000, Bhatia et al., 2009].  
Naive and sham treatment did not create any considerable outcome, when compared together 
(data not shown). Therefore, only observations related to sham group have been discussed. 
Ac
ce
pt
d M
an
us
cri
pt
 13 
 
Fig. 4b-f. portrays the histological characteristics of haematoxylin-eosin stained mouse tail 
skin sections after various treatments. 
Group 2 (sham) depicts distinct signs of parakeratosis (Fig. 4b), a high density of 
keratinocytes with nucleus and reduction in granular layer was observed. Two weeks 
treatment with BONS gel (5%w/v) formulation (Fig.4e) resulted in marked histological 
variations in tail skin section as orthokeratotic stratum corneum spread longitudinally into the 
previously present parakeratotic condition. It was also observed, all the treatment groups 
revealed different orthokeratosis (OK) scores as well as drug activity as represented in Table 
2. The results indicated that BONS gel possessed remarkably enhanced (p<0.05) antipsoriatic 
activity in comparison to sham (Fig.4b), CP gel (0.05%w/v) (Fig.4f) and BO gel (5%w/v) 
(Fig. 4c). Also, BONS gel revealed comparable antipsoriatic activity to BO gel (10%w/v) 
(Fig.4d) indicating that encapsulation of BO in cyclodextin nanostructures would lead to 
dose reduction by half as compared unencapsulated essential oil. The augumented action of 
the BONS gels (5%w/v) (Fig.4e) could be attributed to its penetration of nanosize oil loaded 
nanosponge particles and targeted delivery to the epidermal layers of skin. These results are 
in consonance with improved therapeutic efficacy observed with topical nanosponges of 
lemongrass oil [Aldawsari et al., 2015]. Further, the results of current work are also in 
consonance with previous findings on anti-psoriatic activity of liposomal fusidic acid using 
the mouse tail model [Wadhwa et al., 2016]. 
3.8. Biocompatibility and Safety  
In order to evaluate the safety of prepared BONS gels, visual and histopathological 
observations were assessed after their topical application. Visual observation showed no sign 
of skin irritation such as swelling and erythema after application of BONS gel. Further, 
histopathology images depicted no noticeable changes in tail skin of BONS treated groups in 
comparison with normal tail skin. The results advocate skin compatibility and safety of 
prepared nanosystem for topical delivery of babchi essential oil. 
3.9. Biochemical assessment 
Psoriasis is associated with proliferation and activation of keratinocytes and immune cells, 
hence, oxidative stress is likely to play a indispensable role in its pathogenesis. Oxidative 
stress involves imbalance between ROS and antioxidants resulting in molecular abnormalities 
and disruption of redox signalling. This redox imbalance plays a vital role in psoriasis 
pathogenesis. Mammalian cells possess an antioxidant defence mechanism, including GSH, 
SOD, catalase, perxiredoxins, thioredoxins, small molecules such as uric acid [Harrison, 
2014]. Numerous studies revealed that significantly enhanced levels of oxidative stress 
markers along with decreased activity of antioxidant enzymes may participate much in 
pathogenesis of psoriasis [Panonnummal et al., 2017]. Hence in the present investigation, we 
explored the role of ROS in mouse tail model and the effect of babchi oil and its 
nanostructures on the oxidative stress markers. 
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3.9.1. Estimation of nitrite 
Nitric oxide (free radical) is produced by nitric oxide synthase mediated biotransformation. 
Generally, high levels of NO released by skin is known to play potential role in keratinocyte 
proliferation, a common symptom of psoriasis [Tekin et al., 2006]. As a vasodilator it is 
involved in numerous inflammatory reactions, causing edema, increased vascular 
permeability, erythema and increased cell infiltration, by enhancing local blood flow in the 
skin microcirculation [Rhodes et al., 2001, Kadam et al., 2010]. Hence, NO is a vital marker 
of inflammation, particularly in psoriasis.  The production of nitric oxide is 10-fold higher in 
nonlesional psoriatic skin and in the plaques [Weller and Ormerod, 1997]. In the present 
investigation, levels of NO followed the order: sham group (blank Carbopol gel)˃ CP gel 
(0.05%w/v)˃ BO gel (5%w/v)> BO gel (10%w/v)> BONS gel (5%w/v), respectively in 
mouse tail skin (Fig. 5a). 
Further, NO levels were observed to be significantly lower in BONS gel group (p<0.001) in 
comparison to BO gel (5%w/v), CP gel (0.05%w/v) and sham groups but were comparable to 
BO gel (10%w/v) (Fig. 5a) clearly evidencing its superior efficacy as the effect is equivalent 
to conventional gel containing double the concentration of BO. These observations are in 
accordance with the histopathological results providing complimentary evidence for 
enhanced therapeutic activity of BONS gel.  
3.9.2. Measurement of SOD levels 
SOD, an endogenous enzymatic scavenger, acts as first line of protection against oxidative 
stress responsible for converting superoxide anion into H2O2 (hydrogen peroxide)
 
[Briganti 
and Picardo, 2003, Kadam et al., 2010]. Reduced SOD levels might be associated to 
epidermal hyperproliferation, as ROS are likely to induce proliferation in various cells 
[Kobayashi et al., 1991, Iizuka and Takahashi, 1993]. Enhanced oxygen metabolism has been 
related with hyper proliferation owing to significant enzyme depletion inside the psoriatic 
skin. High superoxide anion (O2
•-
) production along with reduced antioxidant activity would 
led to accumulation of H2O2, which is responsible for inhibition action of SOD function 
[Iizuka and Takahashi, 1993, Górnicki and Gutsze, 2001]. Our results support the reduced 
SOD level in psoriatic skin as seen in control group, however on treatment with BONS gel 
the SOD levels were found to revert back. SOD levels were found to be significantly higher 
in the BONS gel (5%w/v) treated animals (p˂ 0.001) as compared to control, CP gel 
(0.05%w/v) and BO gel (5%w/v). However, the values were found comparable to BO gel 
(10%w/v) (Fig. 5b). These results are in corroboration with those obtained for NO levels. 
3.9.3. Estimation of Lipid peroxidation 
ROS influence oxidation of the polyunsaturated fatty acids in skin resulting in the formation 
of MDA [Carini et al., 2000], a biomarker of lipid peroxidation [Lykkesfeldt, 2007]. 
Enhanced LPO is known to induce inflammatory and immune responses, in addition to cell 
proliferation and activation of gene expression of cytokines.  MDA tissue levels have been 
found to be higher in psoriatic lesions than in nonlesional tissues [Şikar et al., 2012]. Our 
results demonstrated that topical application of BONS gel resulted in significantly reduced 
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MDA level in comparison to blank gel, CP gel (0.05%w/v) and BO gel (5%w/v) with p value 
below 0.05 (Fig. 5c). Nevertheless, in comparison to BO gel (10%w/v), the MDA levels for 
BONS (5%w/v) nanogel were observed to be similar demonstrating efficacy of nanogel was 
equivalent to that observed with double the concentration of unencapsulated oil dinstinctingly 
illustrating the merit of nanostructure gel.     
3.9.4. Measurement of GSH levels 
GSH (a ubiquitous tripeptide thiol) is a vital extracellular and intracellular protective 
antioxidant [Carini et al., 2000]. It is highly polarisable and results in removal of radicals 
directly, owing to its property to neutralise excess production of ROS.This results in 
depeletion of its level. On topical treatment with BONS gel, GSH levels were found be 
enhanced (p˂ 0.05) when compared to plain gel, CP gel and BO gel (Fig. 5d) indicating 
reduced oxidative stress. 
This biochemical estimation of MDA, GSH, SOD and nitrite levels provides an evidence for 
enhanced ROS production and poor antioxidant defences in psoriatic disease. However on 
treatment with BONS gel there was clear indication of reduction in oxidative stress and 
distinct induction of orthokeratosis. This was reflected by high GSH and SOD and reduced 
MDA and NO levels on treatment with BONS gels. 
4. Conclusion 
The present study advocates a novel cyclodextrin based nanocarrier gel of babchi oil for 
treatment of psoriasis. The BO encapsulated nanoparticles were successfully fabricated using 
diphenyl carbonate as crosslinker and incorporated into Carbopol 934 gel. Fabricated 
nanosponges resulted in high entrapment of BO. The nanogels displayed psuedoplastic 
behaviour with good spreadability and exhibited sustained release of BO warranting once 
dailt application, which, would be beneficial in improving patient compliance in chronic 
therapy of psoriasis. Two times enhanced anti-psoriatic activity was demonstrated in mouse-
tail model, without any apparent skin irritation or symptoms like inflammation and erythema. 
Histological parameters along with biochemical assessment of oxidative stress biomarkers 
(enhanced level of SOD and GSH and decreased level of MDA and NO), provided evidence 
that BO nanoparticles gel plays a major role in management of ROS associated in psoriasis 
pathogenesis. In conclusion, topical babchi oil nanogel holds great promise in psoriasis 
treatment and warrants further clinical validation in humans for future commercial 
exploitation. 
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Figure captions 
Figure 1 Experimental protocol. MDA malondialdehyde.  
Figure 2 a) Differential scanning calorimetry (DSC) thermograms of BO (Babchi oil), BONS 
(Babchi oil loaded nanostructures), BNS (Blank nanostructures), DPC (Diphenyl carbonate) 
and β-CD (β-cyclodextrin); b) Fourier transform infrared (FTIR) spectra of BO (Babchi Oil), 
Blank gel (Blank Carbopol gel), BO gel (Babchi oil loaded gel) and BONS gel (Babchi oil 
nanostructures loaded gel). 
 
Figure 3 Evaluation of Carbopol gels (a) Shear rate vs measured viscosity curves of Carbopol 
gels and (b) Graphical representation of the spreadability of fabricated gels determined by 
parallel plate method (mean±standard deviation; N=3). 
Figure 4a Cumulative babchi oil released from BO gel and BONS gel (mean ± standard 
deviation, N3). Histopathological evaluation of mice tail skin after various treatments (b) 
Control (c)BO gel 5%w/v (d) BO gel 10%w/v and (e) BONS gel 5%w/v (f) CP gel 
0.05%w/v. Calibration bar100µm 
Figure 5 The mean levels of NO expression (a), sodium dismutase (b), MDA (c) and reduced 
glutathione (d) in the tail skin tissue of mice treated topically from different experiment 
groups. N = 6 each group. Data are in mean ± SD. Data were analyzed by one way ANOVA 
followed by Tukey’s test for multiple comparisons. BO: Babchi oil gel, BONS: Babchi oil 
loaded nanostructures gel, CP: Clobetasol propionate gel. 
For Figure a: 
a
 p < 0.001 versus control, 
b
 p < 0.001 versus BO 5%w/v gel 
For Figure b: 
a
 p < 0.001 versus control, 
b
 p < 0.001 versus BO 5%w/v gel 
For Figure c: 
a
 p < 0.05 versus control, 
b
 p < 0.001 versus control, 
c
 p < 0.01 versus BO 5%w/v gel 
For Figure d: 
 a
 p < 0.05 versus control, 
b
 p < 0.001 versus control,
 c 
p < 0.05 versus BO 5%w/v gel, 
d
 p < 0.001 
versus BO 5%w/v gel, 
e
 p < 0.01 versus BO 10%w/v gel 
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Figure 1 Experimental protocol. MDA malondialdehyde.  
 
 
 
 
Figure 2 a) Differential scanning calorimetry (DSC) thermograms of BO (Babchi oil), BONS 
(Babchi oil loaded nanostructures), BNS (Blank nanostructures), DPC (Diphenyl carbonate) 
and β-CD (β-cyclodextrin); b) Fourier transform infrared (FTIR) spectra of BO (Babchi Oil), 
Blank gel (Blank Carbopol gel), BO gel (Babchi oil loaded gel) and BONS gel (Babchi oil 
nanostructures loaded gel). 
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Figure 3 Evaluation of Carbopol gels (a) Shear rate vs measured viscosity curves of Carbopol 
gels and (b) Graphical representation of the spreadability of fabricated gels determined by 
parallel plate method (mean± standard deviation; N=3). 
 
 
 
Figure 4a Cumulative babchi oil released from BO gel and BONS gel (mean ± standard deviation, N3). 
Histopathological evaluation of mice tail skin after various treatments (b) Control (c)BO gel 5%w/v (d) BO gel 
10%w/v and (e) BONS gel 5%w/v (f) CP gel 0.05%w/v. Calibration bar100µm 
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Figure 5 The mean levels of NO expression (a), sodium dismutase (b), MDA (c) and reduced 
glutathione (d) in the tail skin tissue of mice treated topically from different experiment 
groups. N = 6 each group. Data are in mean ± SD. Data were analyzed by one way ANOVA 
followed by Tukey’s test for multiple comparisons. BO: Babchi oil gel, BONS: Babchi oil 
loaded nanostructures gel, CP: Clobetasol propionate gel. 
For Figure a: 
a
 p < 0.001 versus control, 
b
 p < 0.001 versus BO 5%w/v gel 
For Figure b: 
a
 p < 0.001 versus control, 
b
 p < 0.001 versus BO 5%w/v gel 
For Figure c: 
a
 p < 0.05 versus control, 
b
 p < 0.001 versus control, 
c
 p < 0.01 versus BO 5%w/v gel 
For Figure d: 
 a
 p < 0.05 versus control, 
b
 p < 0.001 versus control,
 c 
p < 0.05 versus BO 5%w/v gel, 
d
 p < 0.001 
versus BO 5%w/v gel, 
e
 p < 0.01 versus BO 10%w/v gel 
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Table captions 
 
Table 1 Hardness, work of cohesion and adhesion, and springiness for the different tested samples, recorded at 
room temperature.  
Sample  Hardness (N)  
±SD 
Work of adhesion 
(N sec) ±SD 
Work of cohesion 
±SD 
Springiness ±SD  
Plain gel 0.24±0.07
 
-4.48±0.22 0.76±0.034 0.93±0.109 
BO gel (5%w/v) 0.51±0.01 -4.36±0.22 0.81±0.005 0.90±0.035 
BONS gel (5%w/v) 0.25±0.01 -1.13±0.18 0.84±0.035 0.91±0.056 
 
 
 
Table 2 Change in epidermal thickness, percent orthokeratosis and percent drug activity of 
different gel formulations. 
 
Sr. No. Formulation Relative epidermal 
thickness ± SD 
% Orthokeratosis  
± SD 
Drug activity  
± SD 
1. Plain gel 100±0.00 47.28±1.32 00.00±0.00 
2. BO gel (5% w/v) 56.73±4.43
a,c
 60.59±1.58
a
 25.17±4.82
a
 
3. BO gel (10% w/v) 42.32±5.81
a,b
 67.67±0.91
a,b
 38.62±3.21
a,b
 
4. BONS gel (5% w/v) 30.44±5.86
a,b,c
 73.66±2.20
a,b,c
 50.06±3.58
a,b,c
 
5. CP gel (0.05% w/v) 69.52±4.50
a
 58.11±1.01
a
 26.64±2.61
a
 
N= 6 per group, Statistical data analysis from the one-way ANOVA followed by Tukey’s test for multiple comparisons. (Relative epidermal 
thickness, % Orthokeratosis, Drug activity: a p < 0.001 versus plain gel, b p < 0.001 versus BO gel 5% w/v, c p < 0.001 versus BO gel 10% 
w/v, BO: Babchi oil gel, BONS: Babchi oil loaded nanostructure gel, CP: Clobetasol propionate gel.  
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